بدائل البحث:
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
c large » a large (توسيع البحث), b large (توسيع البحث), i large (توسيع البحث)
large decrease » larger decrease (توسيع البحث), marked decrease (توسيع البحث), large increases (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
c large » a large (توسيع البحث), b large (توسيع البحث), i large (توسيع البحث)
-
1
ECoG timescales decrease during spatial attention.
منشور في 2025"…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …"
-
2
-
3
-
4
-
5
-
6
-
7
-
8
In the first 15 days of pod fill high temperature over 30∘C decreased marketable yield for both seasons.
منشور في 2025"…<p>In the first 15 days of pod fill high temperature over 30∘C decreased marketable yield for both seasons.</p>…"
-
9
-
10
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
منشور في 2025"…(C) Mutualism also promotes an increase in network connectance when introduced into assembled communities, while stopping mutualistic interactions from entering an assembled system slowly decreases it. …"
-
11
Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas
منشور في 2025"…Moreover, annual colony losses also decreased with higher abundance of surrounding forested area. …"
-
12
Expression of lipid biosynthetic genes is decreased with polyamine depletion.
منشور في 2024الموضوعات: -
13
-
14
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: -
15
-
16
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
منشور في 2025الموضوعات: -
17
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
18
-
19
Baseline patient characteristics across neutralizing monoclonal antibody trials.
منشور في 2025الموضوعات: -
20